SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Neuberger J. Liver transplantation. J Hepatol 2000; 32(1 Suppl ): 198207.
  • 2
    Plotkin JS, Scott VL, Pinna A, Dobsch BP, DeWolf AM, Kang Y. Morbidity and mortality in patients with coronary arery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996; 2: 426430.
  • 3
    Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73: 901906.
  • 4
    Poldermans D, Arnese M, Fioretti PM, Boersma E, Thomson IR, Rambaldi R, van Urk H. Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery. Circulation 1997; 95: 5358.
  • 5
    Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events. Am Heart J 1996; 131: 923929.
  • 6
    Kryzhanovski VA, Beller GA. Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation. Am J Cardiol 1997 79: 986988.
  • 7
    Davidson CJ, Gheorghiade M, Flaherty JD, Elliott MD, Reddy SP, Wang NC, Sundaram SA, et al. Predictive value of stress myocardial perfusion imaging in liver transplant candidates. Am J Cardiol 2002; 89: 359360.
  • 8
    Zoghbi GJ, Patel AD, Ershadi RE, Heo J, Bynon JS, Iskandrian AE. Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation. Am J Cardiol 2003; 92: 10661071.
  • 9
    Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, Armstrong WF. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61: 11801188.
  • 10
    Plotkin JS, Benitez RM, Kuo PC, Njoku MJ, Ridge LA, Lim JW, Howell CD, et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg 1998 4: 337339.
  • 11
    Williams K, Lewis JF, Davis G, Geiser EA. Dobutamine stress echocardiography in patients undergoing liver transplantation evaluation. Transplantation 2000; 69: 23542456.
  • 12
    Neal DA, Tom BD, Luan J, Wareham NJ, Gimson AE, Delriviere LD, Byrne CD, et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation 2004; 77: 9399.
  • 13
    Guckelberger O, Byram A, Klupp J, Neumann UP, Glanemann M, Stockmann M, Neuhaus R, et al. Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk-factors. Transpl Int 2005; 18: 967974.
  • 14
    Abbasoglu O, Levy MF, Brkic BB, Testa G, Jeyarajah DR, Goldstein RM, Husberg BS, et al. Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation 1997; 64: 18011807.
  • 15
    Guckelberger O, Mutzke F, Glanemann M, Neumann UP, Jonas S, Neuhaus R, Neuhaus P, et al. Validation of Cardiovascular risk scores in a liver transplant population. Liver Transpl 2006; 12: 394401.
  • 16
    Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med 2004; 23: 16311660.
  • 17
    Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 1999; 81: 4046.
  • 18
    Cullen P, Schulte H, Assmann G. The Münster Heart Study (PROCAM). Total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers. Circulation 1997; 96: 21283216.
  • 19
    Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 9871003.